Home/Filings/4/0000943819-25-000184
4//SEC Filing

Sandercock Brett 4

Accession 0000943819-25-000184

CIK 0000943819other

Filed

Dec 1, 7:00 PM ET

Accepted

Dec 2, 4:23 PM ET

Size

4.5 KB

Accession

0000943819-25-000184

Insider Transaction Report

Form 4
Period: 2025-12-01
Sandercock Brett
Chief Financial Officer
Transactions
  • Sale

    ResMed Common Stock

    2025-12-01$244.16/sh1,000$244,16087,495 total
Footnotes (1)
  • [F1]The transaction was conducted under a Rule 10b5-1 plan adopted February 19, 2025.

Issuer

RESMED INC

CIK 0000943819

Entity typeother

Related Parties

1
  • filerCIK 0001346064

Filing Metadata

Form type
4
Filed
Dec 1, 7:00 PM ET
Accepted
Dec 2, 4:23 PM ET
Size
4.5 KB